Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biodegradation of Brimonidine Tartrate PS DDS
NCT01080209Phase 2Completed
- Sponsor
- Allergan
- Start
- Feb 2010
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 12
01
Overview
A Phase 2 trial of brimonidine in geographic atrophy (GA), retinal detachment, sponsored by Allergan. Started Feb 2010; status: completed.
02
Drugs
brimonidine
03
Conditions
geographic atrophy (GA)retinal detachment
Beyond the preview
Go deeper on NCT01080209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01080209.